Findings on TTE during inpatient hospitalisation for ischaemic stroke versus a most recent prior TTE (left) and inpatient TTE versus follow-up TTE (right)
| TTE features | Comparison of findings of inpatient TTE and most recent prior TTE (n=1106) | Comparison of findings of inpatient TTE and first follow-up TTE (n=1077) | ||||
| Most recent prior TTE N (%) | Inpatient TTE N (%) | P value | Inpatient TTE N (%) | Follow-up TTE N (%) | P value | |
| Tumour (left-sided) | 0 (0) | 0 (0.0) | 1.000 | 0 (0.00) | 0 (0.00) | 1.000 |
| Vegetation (left-sided) | 1 (0.09) | 5 (0.45) | 0.219 | 4 (0.4) | 1 (0.1) | 0.250 |
| Patent foramen ovale | 88 (8.0) | 131 (11.8) | <0.001 | 258 (24.0) | 128 (11.9) | <0.001 |
| Atrial septal aneurysm | 1 (0.2) | 10 (2.9) | 0.250 | 20 (1.9) | 5 (0.5) | <0.001 |
| Left atrium, dilated | 589 (53.3) | 632 (57.1) | 0.007 | 490 (45.5) | 555 (51.5) | <0.001 |
| LV aneurysm | 18 (1.6) | 25 (2.3) | 0.265 | 20 (1.9) | 20 (1.9) | 1.000 |
| LV thrombus | 6 (0.54) | 16 (1.45) | 0.031* | 18 (1.7) | 12 (1.1) | 0.327 |
| LV hypertrophy | 331 (29.9) | 368 (33.3) | 0.014* | 289 (26.8) | 273 (25.4) | 0.284 |
| LV wall motion abnormality | 201 (18.2) | 214 (19.4) | 0.287 | 157 (14.6) | 184 (17.1) | 0.026 |
| EF ≤15% | 2 (0.2) | 13 (1.2) | 0.001* | 16 (1.5) | 6 (0.6) | 0.031 |
| EF ≤35% | 66 (6.0) | 104 (9.4) | <0.001 | 95 (8.8) | 92 (8.5) | 0.810 |
| Lambl’s excrescence | 14 (1.3) | 30 (2.7) | 0.003* | 14 (1.3) | 18 (1.7) | 0.524 |
| Mitral annular calcification | 485 (43.91) | 545 (49.3) | <0.001 | 366 (34.0) | 406 (37.7) | 0.003 |
| Aortic atheroma | 193 (17.5) | 244 (22.1) | 0.003* | 174 (16.2) | 159 (14.8) | 0.342 |
| Prosthesis | 30 (2.7) | 46 (4.2) | 0.009* | 22 (2.04) | 25 (2.32) | 0.607 |
| Moderate or severe aortic regurgitation | 27 (2.4) | 40 (3.6) | 0.053 | 21 (2.0) | 28 (2.6) | 0.248 |
| Moderate or severe mitral regurgitation | 155 (14.0) | 177 (16.0) | 0.067 | 116 (10.8) | 155 (14.4) | <0.001 |
| Aortic stenosis | 37 (3.4) | 34 (3.1) | 0.804 | 26 (2.4) | 32 (3.0) | 0.489 |
| Mitral stenosis | 25 (2.3) | 26 (2.4) | 1.000 | 19 (1.8) | 19 (1.8) | 1.000 |
*Median days between most recent prior TTE and inpatient TTE is 539 days (IQR 162–1317 days); median days between inpatient TTEs and follow-up TTE is 481 days (IQR 212–1065 days)
EF, ejection fraction; LV, left ventricular; TTE, transthoracic echocardiogrphy.